Targeting mitochondrial energy metabolism with TSPO ligands

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 537-542

  Gut, Philipp ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Diabetes mellitus; Metabolic disease; Mitochondria; Mitochondrial drugs; PK 11195; Zebrafish

Indexed keywords

CARRIER PROTEIN; MITOCHONDRIAL PROTEIN; 4 AMINOBUTYRIC ACID RECEPTOR; LIGAND; TSPO PROTEIN, HUMAN;

ARTICLE; CELL METABOLISM; CHRONIC DISEASE; CYTOSOL; DIET; ENERGY METABOLISM; HUMAN; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; MITOCHONDRIAL TARGETING SIGNAL; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; UPREGULATION; ANIMAL; DRUG EFFECTS; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION;

DANIO RERIO;

ANIMALS; CYTOSOL; ENERGY METABOLISM; HUMANS; LIGANDS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; RECEPTORS, GABA; UP-REGULATION;

EID: 84938775711     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150019     Document Type: Article

References (42)

1. Andreux, P.A., Houtkooper, R.H. and Auwerx, J. (2013) Pharmacological approaches to restore mitochondrial function. Nat. Rev. Drug. Discov. 12, 465-483 CrossRef PubMed
2. Lopez-Otin, C., Blasco, M.A., Partridge, L., Serrano, M. and Kroemer, G. (2013) The hallmarks of aging. Cell 153, 1194-1217 CrossRef PubMed
3. Schon, E.A. and Przedborski, S. (2011) Mitochondria: the next (neurode)generation. Neuron 70, 1033-1053 CrossRef PubMed
4. Szendroedi, J., Phielix, E. and Roden, M. (2012) The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8, 92-103 CrossRef
5. Wenz, T., Diaz, F., Spiegelman, B.M. and Moraes, C.T. (2008) Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 8, 249-256 CrossRef PubMed
6. Samuel, V.T., Liu, Z.X., Qu, X., Elder, B.D., Bilz, S., Befroy, D., Romanelli, A.J. and Shulman, G.I. (2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279, 32345-32353 CrossRef PubMed
7. Papadopoulos, V., Baraldi, M., Guilarte, T.R., Knudsen, T.B., Lacapere, J.J., Lindemann, P., Norenberg, M.D., Nutt, D., Weizman, A., Zhang, M.R. and Gavish, M. (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci. 27, 402-409 CrossRef PubMed
8. Jaremko, L., Jaremko, M., Giller, K., Becker, S. and Zweckstetter, M. (2014) Structure of the mitochondrial translocator protein in complex with a diagnostic ligand. Science 343, 1363-1366 CrossRef PubMed
9. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T.C., Fan, J., Akula, N., Groyer, G., Adams, D. and Schumacher, M. (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug. Discov. 9, 971-988 CrossRef PubMed
10. Barron, A.M., Garcia-Segura, L.M., Caruso, D., Jayaraman, A., Lee, J.W., Melcangi, R.C. and Pike, C.J. (2013) Ligand for translocator protein reverses pathology in a mouse model of Alzheimer's disease. J. Neurosci. 33, 8891-8897 CrossRef PubMed
11. Giatti, S., Pesaresi, M., Cavaletti, G., Bianchi, R., Carozzi, V., Lombardi, R., Maschi, O., Lauria, G., Garcia-Segura, L.M., Caruso, D. and Melcangi, R.C. (2009) Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience 164, 520-529 CrossRef PubMed
12. Gut, P., Baeza-Raja, B., Andersson, O., Hasenkamp, L., Hsiao, J., Hesselson, D., Akassoglou, K., Verdin, E., Hirschey, M.D. and Stainier, D.Y. (2013) Whole-organism screening for gluconeogenesis identifies activators of fasting metabolism. Nat. Chem. Biol. 9, 97-104 CrossRef PubMed
13. Gatliff, J. and Campanella, M. (2012) The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr. Mol. Med. 12, 356-368 PubMed
14. Liu, G.J., Middleton, R.J., Hatty, C.R., Kam, W.W., Chan, R., Pham, T., Harrison-Brown, M., Dodson, E., Veale, K. and Banati, R.B. (2014) The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol. 24, 631-653 CrossRef PubMed
15. Vander Heiden, M.G., Lunt, S.Y., Dayton, T.L., Fiske, B.P., Israelsen, W.J., Mattaini, K.R., Vokes, N.I., Stephanopoulos, G., Cantley, L.C., Metallo, C.M. and Locasale, J.W. (2011) Metabolic pathway alterations that support cell proliferation. Cold Spring Harb. Symp. Quant. Biol. 76, 325-334 CrossRef PubMed
16. Banati, R.B., Middleton, R.J., Chan, R., Hatty, C.R., Wai-Ying Kam, W., Quin, C., Graeber, M.B., Parmar, A., Zahra, D., Callaghan, P. et al. (2014) Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat. Commun. 5, 5452 CrossRef PubMed
17. Sileikyte, J., Blachly-Dyson, E., Sewell, R., Carpi, A., Menabo, R., Di Lisa, F., Ricchelli, F., Bernardi, P. and Forte, M. (2014) Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (Translocator Protein of 18 kDa (TSPO)). J. Biol. Chem. 289, 13769-13781 CrossRef PubMed
18. Lin, R., Angelin, A., Da Settimo, F., Martini, C., Taliani, S., Zhu, S. and Wallace, D.C. (2014) Genetic analysis of dTSPO, an outer mitochondrial membrane protein, reveals its functions in apoptosis, longevity, and Ab42-induced neurodegeneration. Aging Cell 13, 507-518 CrossRef PubMed
19. Li, H. and Papadopoulos, V. (1998) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139, 4991-4997 PubMed
20. Taketani, S., Kohno, H., Furukawa, T. and Tokunaga, R. (1995) Involvement of peripheral-type benzodiazepine receptors in the intracellular transport of heme and porphyrins. J. Biochem. 117, 875-880 PubMed
21. Gut, P. and Verdin, E. (2013) The nexus of chromatin regulation and intermediary metabolism. Nature 502, 489-498 CrossRef PubMed
22. Shimazu, T., Hirschey, M.D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C.A., Lim, H., Saunders, L.R., Stevens, R.D. et al. (2013) Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 339, 211-214 CrossRef PubMed
23. Winder, W.W. and Hardie, D.G. (1996) Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise. Am. J. Physiol. 270, E299-E304 PubMed
24. Bouskila, M., Hunter, R.W., Ibrahim, A.F., Delattre, L., Peggie, M., van Diepen, J.A., Voshol, P.J., Jensen, J. and Sakamoto, K. (2010) Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. Cell Metab. 12, 456-466 CrossRef PubMed
25. Garnier, M., Boujrad, N., Ogwuegbu, S.O., Hudson, Jr, J.R. and Papadopoulos, V. (1994) The polypeptide diazepam-binding inhibitor and a higher affinity mitochondrial peripheral-type benzodiazepine receptor sustain constitutive steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 269, 22105-22112 PubMed
26. Handschin, C., Lin, J., Rhee, J., Peyer, A.K., Chin, S., Wu, P.H., Meyer, U.A. and Spiegelman, B.M. (2005) Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 122, 505-515 CrossRef PubMed
27. Papadopoulos, V., Berkovich, A., Krueger, K.E., Costa, E. and Guidotti, A. (1991) Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology 129, 1481-1488 CrossRef PubMed
28. Neess, D., Kiilerich, P., Sandberg, M.B., Helledie, T., Nielsen, R. and Mandrup, S. (2006) ACBP-a PPAR and SREBP modulated housekeeping gene. Mol. Cell Biochem. 284, 149-157 CrossRef PubMed
29. Neess, D., Bloksgaard, M., Bek, S., Marcher, A.B., Elle, I.C., Helledie, T., Due, M., Pagmantidis, V., Finsen, B., Wilbertz, J. et al. (2011) Disruption of the acyl-CoA-binding protein gene delays hepatic adaptation to metabolic changes at weaning. J. Biol. Chem. 286, 3460-3472 CrossRef PubMed
30. Daugherty, D.J., Selvaraj, V., Chechneva, O.V., Liu, X.B., Pleasure, D.E. and Deng, W. (2013) A TSPO ligand is protective in a mouse model of multiple sclerosis. EMBO Mol. Med. 5, 891-903 CrossRef PubMed
31. Decaudin, D., Castedo, M., Nemati, F., Beurdeley-Thomas, A., De Pinieux, G., Caron, A., Pouillart, P., Wijdenes, J., Rouillard, D. et al. (2002) Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res. 62, 1388-1393 PubMed
32. Bribes, E., Bourrie, B., Esclangon, M., Galiegue, S., Vidal, H. and Casellas, P. (2002) Involvement of the peripheral benzodiazepine receptor in the development of rheumatoid arthritis in Mrl/lpr mice. Eur. J. Pharmacol. 452, 111-122 CrossRef PubMed
33. Tu, L.N., Morohaku, K., Manna, P.R., Pelton, S.H., Butler, W.R., Stocco, D.M. and Selvaraj, V. (2014) Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J. Biol. Chem. 289, 27444-27454 CrossRef PubMed
34. Papadopoulos, V. (2014) On the role of the translocator protein (18-kDa) TSPO in steroid hormone biosynthesis. Endocrinology 155, 15-20 CrossRef PubMed
35. Ristow, M. and Zarse, K. (2010) How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol. 45, 410-418 CrossRef PubMed
36. Yun, J. and Finkel, T. (2014) Mitohormesis. Cell Metab. 19, 757-766 CrossRef PubMed
37. Baur, J.A., Ungvari, Z., Minor, R.K., Le Couteur, D.G. and de Cabo, R. (2012) Are sirtuins viable targets for improving healthspan and lifespan? Nat. Rev. Drug. Discov. 11, 443-461 CrossRef
38. Hubbard, B.P., Gomes, A.P., Dai, H., Li, J., Case, A.W., Considine, T., Riera, T.V., Lee, J.E., E, SY, Lamming, D.W. et al. (2013) Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 339, 1216-1219 CrossRef PubMed
39. Seneviratne, M.S., Faccenda, D., De Biase, V. and Campanella, M. (2012) PK11195 inhibits mitophagy targeting the F1Fo-ATPsynthase in Bcl-2 knock-down cells. Curr. Mol. Med. 12, 476-482 PubMed
40. Cleary, J., Johnson, K.M., Opipari, Jr, A.W. and Glick, G.D. (2007) Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor. Bioorg Med. Chem. Lett. 17, 1667-1670 CrossRef PubMed
41. Gledhill, J.R., Montgomery, M.G., Leslie, A.G. and Walker, J.E. (2007) Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols. Proc. Natl. Acad. Sci. U.S.A. 104, 13632-13637 CrossRef PubMed
42. Gut, P. and Verdin, E. (2013) Rejuvenating SIRT1 activators. Cell Metab. 17, 635-637 CrossRef PubMed